These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1489864

  • 1. Immunoassay of CEA, CA 19-9, CA 125, and CA 15-3 on the automated systems ES 300 and ES 600: methodological evaluation from a multicentre collaborative study.
    Zucchelli GC, Pilo A, Jaworek D, Masini S, Chiesa MR.
    Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):875-9. PubMed ID: 1489864
    [Abstract] [Full Text] [Related]

  • 2. A multicentre evaluation of tumour marker determinations using the automatic Enzymun-Test Systems ES 300 and ES 600/700.
    van Dalen A, Kessler AC.
    Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):377-84. PubMed ID: 8704058
    [Abstract] [Full Text] [Related]

  • 3. The CNR external quality assessment program for immunoassays: statistical analysis and reports for participants.
    Pilo A, Zucchelli GC, Chiesa MR, Masini S, Clerico A.
    Ann Ist Super Sanita; 1991 Apr; 27(3):469-77. PubMed ID: 1809067
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A multicentre evaluation of the CA 15-3 assay, CA 19-9 assay and CA 125 II assay on the Bayer Immuno 1 System.
    Römer M, Haeckel R, Brux B, Sinha P, Raiko I, Krieg M, Stark M, Seidel D, Hübner U, Schmitz G.
    Eur J Clin Chem Clin Biochem; 1997 Aug; 35(8):637-44. PubMed ID: 9298356
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [A study of preclinical and clinical usefulness of new tumor markers of ovarian carcinoma, CA 54/61 and CA 602. 1. Evaluation of the diagnostic accuracy of CA 54/61, a study of the normal range of its values and its correlation with other tumor markers].
    Nozawa S, Udagawa Y, Sasaki H, Ito K, Akiya K, Terashima Y, Takamizawa H, Ohkura H, Fujimoto S, Hasimoto M.
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):827-35. PubMed ID: 1605661
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer.
    Eskelinen M, Pasanen P, Kulju A, Janatuinen E, Miettinen P, Poikolainen E, Tarvainen R, Nuutinen P, Pääkkönen M, Alhava E.
    Anticancer Res; 1994 Jun; 14(3B):1427-32. PubMed ID: 8067718
    [Abstract] [Full Text] [Related]

  • 11. Multicenter technical and clinical evaluation of a fully automated enzyme immunoassay for CA 125.
    Kenemans P, Bon GG, Kessler AC, Verstraeten AA, van Kamp GJ.
    Clin Chem; 1992 Aug; 38(8 Pt 1):1466-71. PubMed ID: 1643716
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A comparative study of four serological tumor markers for the detection of breast cancer.
    Clinton SR, Beason KL, Bryant S, Johnson JT, Jackson M, Wilson C, Holifield K, Vincent C, Hall M.
    Biomed Sci Instrum; 2003 Aug; 39():408-14. PubMed ID: 12724928
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancer.
    Hasholzner U, Stieber P, Reiter W, Zimmermann A, Hofmann K, Schalhorn A.
    Anticancer Res; 1999 Aug; 19(4A):2477-80. PubMed ID: 10470177
    [Abstract] [Full Text] [Related]

  • 16. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
    Griesenberg D, Nürnberg R, Bahlo M, Klapdor R.
    Anticancer Res; 1999 Aug; 19(4A):2443-50. PubMed ID: 10470173
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
    Reiter W, Stieber P, Reuter C, Nagel D, Cramer C, Pahl H, Fateh-Moghadam A.
    Anticancer Res; 1997 Aug; 17(4B):2903-6. PubMed ID: 9329559
    [Abstract] [Full Text] [Related]

  • 20. External evaluation of LIAISON tumour marker assays on the fully automated chemiluminescent LIAISON immunoassay analyser.
    Molina R, Bonfrer J, Banfi G, Bugugnani MJ, Cornu F, Hannemann-Pohl K, Hubl W, Merz O, Bach M, Mack M.
    Clin Lab; 2000 Aug; 46(3-4):169-79. PubMed ID: 10791126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.